Sandy Srinivas, MD, on Managing Metastatic Castration-Resistant Prostate Cancer

March 18, 2021 By The ASCO Post Staff

Sandy Srinivas, MD, of Stanford Cancer Institute, discusses the increasing number of ways to deliver life-prolonging therapy to patients with advanced prostate cancer, including more accurate imaging techniques; PET tracers to help better detect, diagnose, and treat disease; PARP inhibitors for BRCA and other mutations; and new sequencing of drugs.

Related Content